Source:http://linkedlifedata.com/resource/pubmed/id/11883045
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2002-3-8
|
| pubmed:commentsCorrections | |
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1438-3276
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
7
|
| pubmed:volume |
144
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
35-7
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading | |
| pubmed:year |
2002
|
| pubmed:articleTitle |
[From neuromuscular blocker to analgesic. What is the value of botulinum toxin in pain therapy?].
|
| pubmed:affiliation |
Oberarzt an der Neurologischen Klinik und Poliklinik, Klinikum rechts der Isar, München. thomas.toelle@neuro.med.tu-muenchen.de
|
| pubmed:publicationType |
Journal Article
|